Booktopia has been placed into Voluntary Administration. Orders have been temporarily suspended, whilst the process for the recapitalisation of Booktopia and/or sale of its business is completed, following which services may be re-established. All enquiries from creditors, including customers with outstanding gift cards and orders and placed prior to 3 July 2024, please visit https://www.mcgrathnicol.com/creditors/booktopia-group/
Add free shipping to your order with these great books
The Law of Off-label Uses of Medicines : Regulation and Litigation in the EU, UK and USA - Andrea Parziale

The Law of Off-label Uses of Medicines

Regulation and Litigation in the EU, UK and USA

By: Andrea Parziale

eBook | 12 August 2022 | Edition Number 1

At a Glance

eBook


$80.99

or 4 interest-free payments of $20.25 with

 or 

Instant Digital Delivery to your Booktopia Reader App

This book examines the regulatory framework for untested and unapproved uses (off-label uses) of medicines in the EU, UK, and USA. Before reaching patients, medicines are extensively tested by manufacturers and approved by regulators to minimise the risk of adverse reactions. However, physicians can prescribe pharmaceuticals for off-label uses, widespread in paediatrics, oncology, rare diseases and, more recently, in treatment for Covid-19. While off-label uses may offer hope, they may also expose patients to risks and uncertainties. Clarification is therefore needed to improve the protection of patients' rights while enhancing legal certainty for health actors.

To this end, this work clarifies the regulatory mechanisms and litigation trends concerning off-licence prescriptions in these jurisdictions. It assesses how traditional, prevention-driven regulatory and civil liability rules are being adapted to tackle potential risks and scientific uncertainty. The book outlines the applicable regulations, as well as considering Brexit's impact on off-label policies in the UK, and EU and national off-label policies in the context of the fight against the Covid-19 pandemic. It also explores under what conditions physicians, manufacturers, or regulators must compensate patients injured by untested prescriptions.

The book will be an essential resource for researchers, academics and policy-makers working in the areas of medical law and ethics, public health law, pharmaceutical law and private comparative law.

on

More in Jurisprudence & General Issues

A Question of Loyalty - Douglas C. Waller

eBOOK

RRP $28.59

$22.99

20%
OFF
Kennedy : The Classic Biography - Ted Sorensen

eBOOK

RRP $31.89

$25.99

19%
OFF
Witness : For the Prosecution of Scott Peterson - Amber Frey

eBOOK

Death & Justice - Mark Fuhrman

eBOOK

RRP $28.59

$22.99

20%
OFF
Ivy Briefs : True Tales of a Neurotic Law Student - Martha Kimes

eBOOK